We are live on ! Find out more

MENS

Jyong Biotech

MENS

Market cap $162M

19 hedge funds and large institutions have $2.73M invested in Jyong Biotech in 2025 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New

Increased

Maintained

Reduced

Closed

550% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 2

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

138% more funds holding

Funds holding: 8 → 19 (+11)

0.77% more ownership

Funds ownership: 0.14% → 0.91% (+0.77%)

34% less capital invested

Capital invested by funds: $4.15M → $2.73M (-$1.42M)

Holders

Holders Change

+11

Holders Change %

+137.5%

% of All Funds

0.23%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	BlackRock New York	+$9.21M
2	UBS Group Zurich, Switzerland	+$5.12M
3	Jane Street New York	+$2.46M
4	Millennium Management New York	+$962K
5	Morgan Stanley New York	+$891K

Top Sellers

Rank	Fund	Capital Flow
1	HF HRT Financial New York	-$819K
2	Citadel Advisors Miami, Florida	-$498K
3	BNP Paribas Financial Markets Paris, France	-$14.1K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	1 BlackRock New York	$1.03M	+$9.21M	+260,823	New
2	2 UBS Group Zurich, Switzerland	$575K	+$5.12M	+145,111	+27,023%
3	3 Jane Street New York	$275K	+$2.46M	+69,560	New
4	4 Geode Capital Management Boston, Massachusetts	$254K	+$372K	+10,538	+20%
5	5 Millennium Management New York	$159K	+$962K	+27,245	+209%
6	6 Morgan Stanley New York	$111K	+$891K	+25,242	+879%
7	7 Bank of America Charlotte, North Carolina	$91.6K	+$819K	+23,182	New
8	8 Man Group London, United Kingdom	$56.2K	+$502K	+14,222	New
9	CUAMC 9 China Universal Asset Management Company Shanghai, China	$48.9K	+$438K	+12,389	New
10	10 Citigroup New York	$43K	+$385K	+10,896	New
11	11 JP Morgan Chase New York	$23.9K	+$214K	+6,051	New
12	TRCT 12 Tower Research Capital (TRC) New York	$18.9K	+$168K	+4,759	+18,304%
13	13 Mirae Asset Global Investments Seoul, South Korea	$14.6K	+$130K	+3,694	New
14	14 Barclays London, United Kingdom	$14K	+$125K	+3,540	New
15	GFM 15 GF Fund Management Guangzhou, China	$5.9K	+$52.7K	+1,493	New
16	16 BNP Paribas Financial Markets Paris, France	$5.13K	-$14.1K	-398	-23%
17	17 Osaic Holdings Scottsdale, Arizona	$1.66K	+$14.8K	+420	New
18	FFA 18 Farther Finance Advisors San Francisco, California	$806	+$7.2K	+204	New
19	CFM 19 Cornerstone Financial Management Burlington, Massachusetts	$55	+$494	+14	New
20	HF 20 HRT Financial New York	–	-$819K	-20,819	Closed
21	21 Citadel Advisors Miami, Florida	–	-$498K	-12,641	Closed

MENS Hedge Fund Activity: Q4 2025 in Review

19 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in Jyong Biotech (MENS) for Q4 2025, worth a combined $2.73M — down 34% from $4.15M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new MENS positions and 2 closed out — a net gain of 11 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $9.21M. The largest seller was HRT Financial, exiting entirely with an estimated $819K sold.

19 institutional investors held Jyong Biotech (MENS) as of Q4 2025, up from 8 in Q3 2025.
Funds reported $2.73M of Jyong Biotech stock for Q4 2025, down 34% quarter-over-quarter.
13 funds opened new Jyong Biotech positions in Q4 2025 and 2 closed out, a net change of +11 holders.
The largest Jyong Biotech buyer in Q4 2025 was BlackRock, an estimated $9.21M added.
The largest Jyong Biotech seller in Q4 2025 was HRT Financial, an estimated $819K sold.

Based on aggregated 13F filings for Q4 2025.

Jyong Biotech MENS Market cap $162M